Reported Reactions

Devices › Prosthesis, breast, noninflatable, internal, silicone gel-filled

Device brand name · Prosthesis breast noninflatable internal silicone gel-filled

Style 153 Silicone Gel Filled Breast Implant: medical device reports filed with FDA

328 reports name it, 2016–2026. Manufacturer given most often on reports: Allergan Costa Rica. Product code FTR.

328
device reports naming the brand
0% of all MAUDE reports · about 31 a year
22
reports, 12 months to August 2026
30 in the 12 months before
0%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 328 reports that name the brand "Style 153 Silicone Gel Filled Breast Implant" (prosthesis breast noninflatable internal silicone gel-filled), received between January 2016 and June 2026; the manufacturer given most often on reports is Allergan Costa Rica. Spellings of one product vary from report to report.

22 reports arrived in the 12 months to August 2026, down 27% from 30 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all prosthesis, breast, noninflatable, internal, silicone gel-filled reports (product code FTR) death is recorded in 0.1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material rupture (76.2%), device appears to trigger rejection (15.9%) and patient-device incompatibility (14.9%). The patient problems coded most often are failure of implant, capsular contracture and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

047Sep 2021: 1Oct 2021: 0Nov 2021: 3Dec 2021: 62022Jan 2022: 1Feb 2022: 1Mar 2022: 4Apr 2022: 1May 2022: 1Jun 2022: 2Jul 2022: 3Aug 2022: 7Sep 2022: 1Oct 2022: 1Nov 2022: 3Dec 2022: 22023Jan 2023: 4Feb 2023: 3Mar 2023: 0Apr 2023: 5May 2023: 3Jun 2023: 0Jul 2023: 4Aug 2023: 1Sep 2023: 4Oct 2023: 5Nov 2023: 4Dec 2023: 02024Jan 2024: 0Feb 2024: 1Mar 2024: 3Apr 2024: 1May 2024: 4Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 1Oct 2024: 3Nov 2024: 0Dec 2024: 62025Jan 2025: 7Feb 2025: 2Mar 2025: 2Apr 2025: 0May 2025: 3Jun 2025: 2Jul 2025: 2Aug 2025: 2Sep 2025: 4Oct 2025: 2Nov 2025: 1Dec 2025: 02026Jan 2026: 5Feb 2026: 1Mar 2026: 2Apr 2026: 2May 2026: 0Jun 2026: 5Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

026522016: 1120162017: 222018: 4520182019: 522020: 3820202021: 392022: 2720222023: 332024: 1920242025: 272026: 152026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%328
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%328
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 231,877 reports carrying product code FTR. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material rupture25076.2%42.7%
Device appears to trigger rejection5215.9%21.6%
Patient-device incompatibilitythe device did not suit the patient4914.9%6.6%
Migrationthe device moved from where it was placed72.1%2.4%
Migration or expulsion of device30.9%0.2%
Gel leak20.6%1.9%
Malposition of device10.3%0.5%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant19659.8%
Capsular contracturescar tissue tightening around an implant10130.8%
Seromaa collection of fluid under the skin164.9%
Lymphomaa cancer of the lymphatic system113.4%
Swollen lymph nodes/glands61.8%
Swollen lymph nodes51.5%
Granuloma41.2%
Anaplastic large cell lymphoma30.9%
Anxietyanxiety20.6%
Bacterial infectiona bacterial infection20.6%
Breast mass20.6%
Inflammationinflammation20.6%
Appropriate clinical signs, symptoms and conditions term/code not available10.3%
Cellulitisa skin infection10.3%
Edemaswelling from fluid10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureStyle 153 Silicone Gel Filled Breast ImplantProduct code FTRAll MAUDE reports
Reports328231,87726,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports019
Classified as injury100%97.7%36.2%
Classified as malfunction0%1.6%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FTR

BrandReportsLatest 12 monthsClassified as death
MENTOR MemoryGel Breast Implant57,7717,7080%
Inspira Smooth Silicone Gel Filled Breast Implant35,6346,7820%
Inspira Textured Silicone Gel Filled Breast Implant24,7952,7660%
Style 410 Cohesive Silicone Gel Filled Breast Implant15,2871,8410.1%
Style 15 Silicone Gel Filled Breast Implant9,5671,5290.1%
Style 20 Silicone Gel Filled Breast Implant6,3689810.1%
Sientra Silicone Gel Breast Implants6,0141,6820%
Style 115 Silicone Gel Filled Breast Implant5,7105460%
Unknown Gel Implants5,3377030%
UNK Gel Breast Implant5,3027820.4%
MENTOR MemoryGel Xtra Breast Implant4,9101,3870%
Inspira Smooth Cohesive Silicone Gel Filled Breast Implant4,6361,0760%
Sientra Opus Silicone Gel Breast Implant4,61300%
Style 110 Silicone Gel Filled Breast Implant3,3642790%
Style 10 Silicone Gel Filled Breast Implant3,3534790.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Style 153 Silicone Gel Filled Breast Implant reports

How many FDA reports name Style 153 Silicone Gel Filled Breast Implant?

328 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 22 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material rupture (76.2%), device appears to trigger rejection (15.9%), patient-device incompatibility (14.9%), migration (2.1%) and migration or expulsion of device (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Style 153 Silicone Gel Filled Breast Implant was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.